Canada markets open in 6 hours 25 minutes
  • S&P/TSX

    21,077.35
    -85.30 (-0.40%)
     
  • S&P 500

    4,701.21
    +14.46 (+0.31%)
     
  • DOW

    35,754.75
    +35.32 (+0.10%)
     
  • CAD/USD

    0.7898
    -0.0008 (-0.10%)
     
  • CRUDE OIL

    72.75
    +0.39 (+0.54%)
     
  • BTC-CAD

    63,329.97
    -992.30 (-1.54%)
     
  • CMC Crypto 200

    1,307.58
    +2.46 (+0.19%)
     
  • GOLD FUTURES

    1,787.30
    +1.80 (+0.10%)
     
  • RUSSELL 2000

    2,271.71
    +17.92 (+0.80%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • NASDAQ futures

    16,395.00
    +2.75 (+0.02%)
     
  • VOLATILITY

    19.90
    -1.99 (-9.09%)
     
  • FTSE

    7,337.05
    0.00 (0.00%)
     
  • NIKKEI 225

    28,725.47
    -135.15 (-0.47%)
     
  • CAD/EUR

    0.6972
    +0.0005 (+0.07%)
     

Global Defibrillators Market | Share ,Trend, Growth Rate ,Application & Top Companies

·3 min read

Global Defibrillators Market was valued at USD 10.9 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2027.

Pune, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Defibrillators square measure devices won’t to deliver therapeutic shock to a patient’s heart in grave conditions like arrhythmia, cardiopathy, and breathless bodily cavity arrhythmia. The medical aid procedure encompasses delivery of an electrical shock to the guts to depolarizes heart muscles and restores its traditional electrical impulse. Growing focus towards public access electronic device (PAD) by the general public & non-public organizations has fuelled the market growth.

Request a Sample Copy of the Research Report: https://qualiketresearch.com/request-sample/Defibrillators-Market/request-sample

Top Key Players of Defibrillators Market

  • Nihon Kohden

  • Mindray Medical

  • Microport

  • Biotronik

  • Metsis Medikal

  • Medtronic

  • Koninklijke Philips N.V

  • Boston Scientific

  • CU Medical Systems

The growth during this market is driven by the rising prevalence of target diseases, growing specialise in providing public-access defibrillators, and coaching and awareness programs on defibrillators. additionally, rising markets and also the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to supply growth opportunities for players within the market. The growing range of internal organ implant procedures and also the accessibility of reimbursements across developed markets square measure the main factors driving the expansion of this end-user section.

In 2016, Boston Scientific signed an agreement in the form of partnership with Mayo Clinic to speed up the event of medical devices partnered whereby each organizations aim to share property rights to develop new medical technologies. Furthermore, defibrillators were found to be extraordinarily helpful in restorative fulminant asystole in COVID19 that additional pushed for the demand for defibrillators within the pandemic state of affairs. Timely corroborative rules and increasing adoption is additional anticipated to produce this market with a profitable growth platform within the next few years.

Click here to get the short-term and long-term impact of COVID-19 on this Market:

https://qualiketresearch.com/reports-details/Defibrillators-Market

Qualiket Research has segmented the global defibrillators market based on Product segment and End User segment, and region

Product Segment

  • Implantable Defibrillators

  • External Defibrillators


End user Segment

  • Home

  • Hospitals

  • Public access market

  • Alternate care market

  • Prehospitals


By region

  • North America

  • Latin America

  • Europe

  • China

  • Asia Pacific

  • Middle East & Africa

Key Insights & Findings:

  • The implantable cardioverter defibrillators segment accounted for the largest share of the defibrillators market in 2019.

  • Factors which act as a contributor for accounting larger share are the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators.

  • The external defibrillator segment is anticipated to show high paying growth over the forecast period. In addition, robot-assisted surgeries were the most promising segment in the market for AI in healthcare as of 2020.

  • The hospitals, clinics, and cardiac centres segment accounted for the largest share of the global market in 2019.

  • Hospital segment dominated the market growth.

  • the public access market section is calculable to register the quickest CAGR of around eight.6% over the forecast amount attributable to the increasing installation of defibrillators at public places

  • North America considered to be the larger share in the region segment in the market.

  • Asia Pacific is expected to expand at the fastest CAGR over the forecast period.

Buy latest study report : https://qualiketresearch.com/paymentgateway/Defibrillators-Market/payment-gateway

About Us


QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

CONTACT: Vishal Thakur Research Support Specialist QualiKet Research 6060 N Central Expy #500, TX 75204, U.S.A Email: sales@qualiketresearch.com Website: https://qualiketresearch.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting